Flavonoid Fraction of Orange and Bergamot Juices Protect Human Lung Epithelial Cells from Hydrogen Peroxide-Induced Oxidative Stress

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Ferlazzo, Nadia ^a   Visalli, Giuseppa ^a   Smeriglio, Antonella ^a   Cirmi, Santa ^a   Lombardo, Giovanni Enrico ^a   Campiglia, Pietro ^b   Di Pietro, Angela ^a   Navarra, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BERGAMOT EXTRACT; CYTOTOXIC AGENT; FLAVONOID; HYDROGEN PEROXIDE; MEMBRANE LIPID; ORANGE EXTRACT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BERGAMOT JUICE; CONTROLLED STUDY; DNA DAMAGE; FRUIT JUICE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LUNG ALVEOLUS EPITHELIUM CELL; MITOCHONDRION; ORANGE JUICE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84938150134     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/957031     Document Type: Article

References (58)

1. L. Zuo, N. P. Otenbaker, B. A. Rose, and K. S. Salisbury, "Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma, " Molecular Immunology, vol. 56, no. 1-2, pp. 57-63, 2013.
2. W. MacNee, "Oxidative stress and lung inflammation in airways disease, " European Journal of Pharmacology, vol. 429, no. 1-3, pp. 195-207, 2001.
3. J. Bousquet and N. G. Khaltaev, Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach, World Health Organization, Geneva, Switzerland, 2007.
4. G. Pelaia, G. Cuda, A. Vatrella et al. , "Effects of hydrogen peroxide onMAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells, " Journal of Cellular Biochemistry, vol. 93, no. 1, pp. 142-152, 2004.
5. R. Maselli, R. D. Grembiale, G. Pelaia, and G. Cuda, "Oxidative stress and lung diseases, "MonaldiArchives for ChestDisease, vol. 57, no. 3-4, pp. 180-181, 2002.
6. C. A. Rice-Evans, N. J. Miller, and G. Paganga, "Antioxidant properties of phenolic compounds, " Trends in Plant Science, vol. 2, no. 4, pp. 152-159, 1997.
7. J. A. Ross and C. M. Kasum, "Dietary flavonoids: bioavailability, metabolic effects, and safety, " Annual Review of Nutrition, vol. 22, pp. 19-34, 2002.
8. V. Di Matteo and E. Esposito, "Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, " Current Drug Target-CNS & Neurological Disorders, vol. 2, no. 2, pp. 95-107, 2003.
9. L. H. Yao, Y. M. Jiang, J. Shi et al. , "Flavonoids in food and their health benefits, " Plant Foods for Human Nutrition, vol. 59, no. 3, pp. 113-122, 2004.
10. S. Kumar and A. K. Pandey, "Chemistry and biological activities of flavonoids: an overview, " The Scientific World Journal, vol. 2013, Article ID162750, 16 pages, 2013.
11. P. Mladenka, K. Macakova, T. Filipsky et al. , "In vitro analysis of iron chelating activity of flavonoids, " Journal of Inorganic Biochemistry, vol. 105, no. 5, pp. 693-701, 2011.
12. C. Chen and A. N. Kong, "Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects, " Trends in Pharmacological Sciences, vol. 26, no. 6, pp. 318-326, 2005.
13. R. Masella, R. Di Benedetto, R. Var, C. Filesi, and C. Giovannini, "Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathionerelated enzymes, " Journal ofNutritional Biochemistry, vol. 16, no. 10, pp. 577-586, 2005.
14. H. Kumar, I. S. Kim, S. V. More, B. W. Kim, and D. K. Choi, "Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases, " Natural Product Reports, vol. 31, no. 1, pp. 109-139, 2014.
15. O. Benavente-Garca and J. Castillo, "Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity, " Journal of Agricultural and Food Chemistry, vol. 56, no. 15, pp. 6185-6205, 2008.
16. G. Grosso, F. Galvano, A. Mistretta et al. , "Red orange: experimental models and epidemiological evidence of its benefits on human health, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 157240, 11 pages, 2013.
17. M. Navarra, C. Mannucci, M. Delbò, and G. Calapai, "Citrus bergamia essential oil: from basic research to clinical application, " Frontiers in Pharmacology, vol. 6, article 36, 2015.
18. A. Marino, I. Paterniti, M. Cordaro et al. , "Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis, " PharmaNutrition, vol. 3, no. 2, pp. 53-59, 2015.
19. S. Delle Monache, P. Sanità, E. Trapasso et al. , "Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice, " PLoS ONE, vol. 8, no. 4, Article ID e61484, 2013.
20. M. Navarra, M. R. Ursino, N. Ferlazzo, M. Russo, U. Schumacher, and U. Valentiner, "Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and inmetastatic xenograft models, " Fitoterapia, vol. 95, pp. 83-92, 2014.
21. G. Visalli, N. Ferlazzo, S. Cirmi et al. , "Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells, " Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 10, pp. 1402-1413, 2014.
22. R. Risitano, M. Currò, S. Cirmi et al. , "Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes, " PLoS ONE, vol. 9, no. 9, Article ID e107431, 2014.
23. D. Impellizzeri, G. Bruschetta, R. Di Paola et al. , "The antiinflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimentalmodel of inflammatory bowel disease, " Clinical Nutrition, 2014.
24. H. A. Smit, L. Grievink, and C. Tabak, "Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence, " Proceedings of the Nutrition Society, vol. 58, no. 2, pp. 309-319, 1999.
25. S. Biswas, J. W. Hwang, P. A. Kirkham, and I. Rahman, "Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease, " Current Medicinal Chemistry, vol. 20, no. 12, pp. 1496-1530, 2013.
26. C. Tabak, I. C. W. Arts, H. A. Smit, D. Heederik, and D. Kromhout, "Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the morgen study, " American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 61-64, 2001.
27. R. K. Woods, E. H. Walters, J. M. Raven et al. , "Food and nutrient intakes and asthma risk in young adults, " American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 414-421, 2003.
28. R. Barros, A. Moreira, J. Fonseca et al. , "Adherence to the Mediterranean diet and fresh fruit intake are associated with improved asthma control, " Allergy, vol. 63, no. 7, pp. 917-923, 2008.
29. E. Keranis, D. Makris, P. Rodopoulou et al. , "Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial, " European Respiratory Journal, vol. 36, no. 4, pp. 774-780, 2010.
30. M. Homma, M. Minami, C. Taniguchi et al. , "Inhibitory effects of lignans and flavonoids in Saiboku-To, a herbal medicine for bronchial asthma, on the release of leukotrienes from human polymorphonuclear leukocytes, " Planta Medica, vol. 66, no. 1, pp. 88-91, 2000.
31. A. Tomaino, M. Martorana, T. Arcoraci, D. Monteleone, C. Giovinazzo, and A. Saija, "Antioxidant activity and phenolic profile of pistachio (Pistacia vera L. , variety Bronte) seeds and skins, " Biochimie, vol. 92, no. 9, pp. 1115-1122, 2010.
32. A. Davalos, C. Gomez-Cordoves, and B. Bartolome, "Extending applicability of the oxygen radical absorbance capacity (ORACfluorescein) assay, " Journal of Agricultural and Food Chemistry, vol. 52, no. 1, pp. 48-54, 2004.
33. M. Martorana, T. Arcoraci, L. Rizza et al. , "In vitro antioxidant and in vivo photoprotective effect of pistachio (Pistacia vera L. , variety Bronte) seed and skin extracts, " Fitoterapia, vol. 85, no. 1, pp. 41-48, 2013.
34. A. Di Pietro, G. Visalli, F. Munaò et al. , "Oxidative damage in human epithelial alveolar cells exposed in vitro to oil fly ash transition metals, " International Journal of Hygiene and Environmental Health, vol. 212, no. 2, pp. 196-208, 2009.
35. A. Di Pietro, B. Baluce, G. Visalli, S. la Maestra, R. Micale, and A. Izzotti, "Ex vivo study for the assessment of behavioral factor and gene polymorphisms in individual susceptibility to oxidative DNA damage metals-induced, " International Journal of Hygiene and Environmental Health, vol. 214, no. 3, pp. 210-218, 2011.
36. E. Ferro, G. Visalli, R. Civa et al. , "Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects, " Free Radical Biology and Medicine, vol. 53, no. 10, pp. 1829-1837, 2012.
37. D. Mangal, D. Vudathala, J.-H. Park, H. L. Seon, T. M. Penning, and I. A. Blair, "Analysis of 7, 8-dihydro-8-oxo-2-deoxyguanosine in cellular DNA during oxidative stress, " Chemical Research in Toxicology, vol. 22, no. 5, pp. 788-797, 2009.
38. I. Picerno, C. Chirico, S. Condello et al. , "Homocysteine induces DNA damage and alterations in proliferative capacity of Tlymphocytes: amodel for immunosenescence" Biogerontology, vol. 8, no. 2, pp. 111-119, 2007.
39. J.-Y. Hsu, J.-J. Chu, M.-C. Chou, and Y.-W. Chen, "Dioscorin pre-treatment protects A549 human airway epithelial cells from hydrogen peroxide-induced oxidative stress, " Inflammation, vol. 36, no. 5, pp. 1013-1019, 2013.
40. P. F. Mercer, R. H. Johns, C. J. Scotton et al. , "Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis, " American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 5, pp. 414-425, 2009.
41. F. Antunes and E. Cadenas, "Cellular titration of apoptosis with steady state concentrations of H2O2: submicromolar levels of H2O2 induce apoptosis through fenton chemistry independent of the cellular thiol state, "FreeRadical BiologyandMedicine, vol. 30, no. 9, pp. 1008-1018, 2001.
42. J. R. Stone and S. Yang, "Hydrogen peroxide: a signaling messenger, " Antioxidants & Redox Signaling, vol. 8, no. 3-4, pp. 243-270, 2006.
43. D. J. Huang, B. X. Ou, and R. L. Prior, "The chemistry behind antioxidant capacity assays, " Journal of Agricultural and Food Chemistry, vol. 53, no. 6, pp. 1841-1856, 2005.
44. C.-D. Zheng, G. Li, H.-Q. Li, X.-J. Xu, J.-M. Gao, and A.-L. Zhang, "DPPH-scavenging activities and structure-activity relationships of phenolic compounds, " Natural Product Communications, vol. 5, no. 11, pp. 1759-1765, 2010.
45. D. Di Majo, M. Giammanco, M. La Guardia, E. Tripoli, S. Giammanco, and E. Finotti, "Flavanones in Citrus fruit: structure-antioxidant activity relationships, " Food Research International, vol. 38, no. 10, pp. 1161-1166, 2005.
46. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, "Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships, " The Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572-584, 2002.
47. J. H. G. Lago, A. C. Toledo-Arruda, M. Mernak et al. , "Structure-Activity association of flavonoids in lung diseases, " Molecules, vol. 19, no. 3, pp. 3570-3595, 2014.
48. Y.-H. Chen, Z.-S. Yang, C.-C. Wen et al. , "Evaluation of the structure-activity relationship of flavonoids as antioxidants and toxicants of zebrafish larvae, " Food Chemistry, vol. 134, no. 2, pp. 717-724, 2012.
49. D. Prochazkova, I. Bousova, and N. Wilhelmova, "Antioxidant and prooxidant properties of flavonoids, " Fitoterapia, vol. 82, no. 4, pp. 513-523, 2011.
50. C. Lopez-Alarcon and A. Denicola, "Evaluating the antioxidant capacity of natural products: a review on chemical and cellularbased assays, " Analytica Chimica Acta, vol. 763, pp. 1-10, 2013.
51. K. Becker, S. Schroecksnadel, J. Gostner et al. , "Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds, " Phytomedicine, vol. 21, no. 2, pp. 164-171, 2014.
52. W. Song, C. M. Derito, M. K. Liu, X. He, M. Dong, andR. H. Liu, "Cellular antioxidant activity of common vegetables, " Journal of Agricultural and Food Chemistry, vol. 58, no. 11, pp. 6621-6629, 2010.
53. K. A. Foster, C. G. Oster, M. M. Mayer, M. L. Avery, and K. L. Audus, "Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism, " Experimental Cell Research, vol. 243, no. 2, pp. 359-366, 1998.
54. P. Paredi, S. A. Kharitonov, D. Leak, S. Ward, D. Cramer, and P. J. Barnes, "Exhaled ethane, a marker of lipid peroxidation, is elevated chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical CareMedicine, vol. 162, no. 2, pp. 369-373, 2000.
55. I. Rahman, "Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms, " Cell Biochemistry and Biophysics, vol. 43, no. 1, pp. 167-188, 2005.
56. J. Nair, S. De Flora, A. Izzotti, and H. Bartsch, "Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions, " Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 621, no. 1-2, pp. 95-105, 2007.
57. I. K. Demedts, T. Demoor, K. R. Bracke, G. F. Joos, and G. G. Brusselle, "Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema, " Respiratory Research, vol. 7, article 53, 2006.
58. J. Lee, S. Giordano, and J. Zhang, "Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling, " Biochemical Journal, vol. 441, no. 2, pp. 523-540, 2012.